z-logo
Premium
Role of CYP 27 B 1+2838 promoter polymorphism in the treatment of chronic hepatitis B HB e A g negative with PEG ‐interferon
Author(s) -
Boglione L.,
Cusato J.,
De Nicolò A.,
Cariti G.,
Di Perri G.,
D'Avolio A.
Publication year - 2015
Publication title -
journal of viral hepatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 100
eISSN - 1365-2893
pISSN - 1352-0504
DOI - 10.1111/jvh.12288
Subject(s) - medicine , hbsag , genotype , gastroenterology , hepatitis b virus , serology , immunology , virus , biology , gene , antibody , biochemistry
Summary In HBV ‐infected patients, the vitamin D deficiency has been related to chronic liver diseases, progression of hepatic fibrosis and poor response to the treatment. The CYP 27B1 gene, which encodes the 1‐ α ‐hidroxylase and involved in the 1,25‐dihydroxyvitamin D synthesis, was recently associated to type‐1 diabetes, autoimmune disorders and treatment response in HCV . Then, we aimed to investigate the role of CYP 27B1 polymorphisms in HBV treatment with PEG ‐ IFN . We retrospectively enrolled 190 patients with chronic hepatitis B HB eAg negative treated for 48 weeks with PEG ‐ IFN α ‐2a. We examined the role of rs4646536 CYP 27 B 1 SNP ( CYP 27 B 1+2838) according to virological and serological response. Our results showed that the TT genotype of CYP 27 B 1+2838 was significantly prevalent in patients with end‐of‐therapy virological response (37.6%) vs CT / CC (9.4%) ( P  < 0.001). Virological relapse was prevalent in patients with CT / CC genotype (12.6%) vs TT genotype (2.1%) ( P  < 0.001). TT genotype was also related to HB sAg loss ( P  = 0.004) and anti‐ HB s appearance ( P  = 0.002). In the multivariate analysis, the TT genotype resulted to be a good positive predictor of sustained virological response ( OR  = 5.632, IC  = 1.938–16.368, P  = 0.001) and serological response ( OR  = 6.161, IC  = 1.856–20.457, P  = 0.003). The CYP 27B1+2838 polymorphism may be useful as pretreatment factor to selection of patients with higher probability of response to therapy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here